Surgery Partners Inc. (SGRY)
NASDAQ · Healthcare
Surgery Partners Inc. EBITDA 2013–2025
Surgery Partners Inc. annual/quarterly ebitda history and growth rate from 2013 to 2026. EBITDA stands for Earnings Before Interest, Taxes, Depreciation and Amortization. It is widely used as a measure of core operational profitability.
- Surgery Partners Inc. ebitda for the quarter ending March 31, 2026 was 104.3 M, a 6.21% increase year-over-year.
- Surgery Partners Inc. ebitda for the twelve months ending March 31, 2026 was 499.7 M, a 10.58% increase year-over-year.
- Surgery Partners Inc. annual ebitda for 2025 was 565.5 M, a 12.78% increase from 2024.
- Surgery Partners Inc. annual ebitda for 2024 was 501.4 M, a 12.40% increase from 2023.
- Surgery Partners Inc. annual ebitda for 2023 was 446.1 M, a 3.02% decrease from 2022.
- Surgery Partners Inc. annual ebitda for 2022 was 460.0 M.
EBITDA
ANNUAL · $B
QUARTERLY · $B
YEAR-OVER-YEAR GROWTH · %
Surgery Partners Inc. EBITDA — FAQ
Surgery Partners Inc. (SGRY) ebitda over the last 12 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see SGRY's ebitda history?
The chart and table above show Surgery Partners Inc.'s ebitda by year and by quarter, including the growth rate.